Clinical trial
Comparing the Efficacy of SYSTANE® PRO to MIEBO™ for the Treatment of Dry Eye Disease
NCT07243275 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing the Efficacy of SYSTANE® PRO to MIEBO™ for the Treatment of Dry Eye Disease
- Lead sponsor
- Indiana University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 18, 2026
- Completion date
- July 28, 2026
- Enrollment
- 269 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye disease (ded)